发表年份

  • 1年内
  • 2年内
  • 3年内
  • 5年内
  • 10年内
  • 更早

产品或服务类型

  • 小鼠
  • 大鼠
  • 细胞
  • 斑马鱼
  • 技术服务
Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy

产品名称：S100a4-2A-CreERT2

研究领域：

发表年份：2024 发表杂志：JOURNAL OF CLINICAL INVESTIGATION

Clinical functional proteomics of intercellular signalling in pancreatic cancer

产品名称：M-NSG

研究领域：肿瘤及肿瘤免疫;胰腺癌

发表年份：2024 发表杂志：NATURE

JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination

产品名称：Nkx3-1-IRES-CreERT2;Krt5-IRES-CreERT2

研究领域：其它;在前列腺炎症或癌症

发表年份：2024 发表杂志：NATURE GENETICS

Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation

产品名称：M-NSG

研究领域：肿瘤及肿瘤免疫;急性髓系白血病

发表年份：2024 发表杂志：Nature Communications

Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies

产品名称：M-NSG

研究领域：肿瘤及肿瘤免疫;B 细胞恶性肿瘤

发表年份：2024 发表杂志：Nature Communications

ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis

产品名称：M-NSG

研究领域：肿瘤及肿瘤免疫;三阴性乳腺癌

发表年份：2024 发表杂志：Journal for ImmunoTherapy of Cancer

Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head

产品名称：Adrb2-KO

研究领域：神经; 股骨头骨坏死 (ONFH) 、糖皮质激素 (GC)

发表年份：2024 发表杂志：Bone Research

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy

产品名称：Rag1-KO(Rag1-EGFP);M-NSG

研究领域：肿瘤及肿瘤免疫;癌症免疫治疗

发表年份：2024 发表杂志：CANCER CELL

Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation

产品名称：Cpt1a-Flox;CAG-GFP-Tg

研究领域：代谢心血管;心脏再生和心肌梗死治疗

发表年份：2024 发表杂志：Acta Pharmaceutica Sinica B

NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia

产品名称：R26-CreERT2

研究领域：肿瘤及肿瘤免疫;急性髓系白血病(AML)异常代谢

发表年份：2024 发表杂志：NATURE CELL BIOLOGY

微信咨询 qrcode 请拨打 400 728 0660 在线咨询 回到顶部